Keyphrases
Breast Cancer Patients
100%
Plasminogen Activator inhibitor-1 (PAI-1)
100%
Tumor Extract
100%
Prognosis Prediction
100%
Low-risk Breast Cancer
100%
Confidence Interval
66%
Relative Risk
66%
Urokinase-type Plasminogen Activator
66%
Recurrence-free Survival
44%
Low Risk
33%
Prognostic Factors
33%
Overall Survival
33%
Receptor 1
33%
Postmenopausal Patients
33%
Breast Cancer
22%
Breast Cancer Risk
22%
Multivariate Analysis
22%
Prognostic Marker
22%
Univariate Analysis
22%
Premenopausal Patients
22%
Published Data
11%
Statistical Significance
11%
Soluble Urokinase Plasminogen Activator Receptor (suPAR)
11%
Prognostic Value
11%
Patient Relatives
11%
Prognostic Significance
11%
Type I Inhibitor
11%
Prognostic Impact
11%
Median Value
11%
Plasminogen Activation System
11%
Urokinase
11%
Sandwich Immunoassay
11%
Node-positive Breast Cancer
11%
Short-term Recurrence
11%
Pharmacology, Toxicology and Pharmaceutical Science
Breast Cancer
100%
Urokinase
100%
Plasminogen Activator Inhibitor 1
100%
Tumor Extract
100%
Receptor
85%
Recurrence Free Survival
57%
Overall Survival
42%
Malignant Neoplasm
28%
Retrospective Study
14%
Enzyme-Linked Immunosorbent Assay
14%
Plasminogen
14%
Urokinase Receptor
14%
Salicylate Sodium
14%
Medicine and Dentistry
Plasminogen Activator Inhibitor-1
100%
Breast Cancer
100%
Tumor Extract
100%
Urokinase
77%
Receptor
66%
Recurrence Free Survival
44%
Overall Survival
33%
Malignant Neoplasm
22%
Multivariate Analysis
22%
Univariate Analysis
22%
Cytosol
22%
Retrospective Study
11%
Plasminogen Activation
11%
Urokinase Receptor
11%
Enzyme Linked Immunosorbent Assay
11%
Salicylate Sodium
11%
Biochemistry, Genetics and Molecular Biology
Urokinase
100%
Plasminogen Activator Inhibitor-1
100%
Tumor Extract
100%
Eicosanoid Receptor
85%
Recurrence Free Survival
57%
Overall Survival
42%
Multivariate Analysis
28%
Enzyme
14%
Urokinase Receptor
14%
Retrospective Study
14%
Plasminogen Activation
14%
Immunology and Microbiology
Recurrence Free Survival
100%
Tumor Extract
100%
Overall Survival
75%
Cytosol
50%
Urokinase Receptor
25%
Enzyme-Linked Immunosorbent Assay
25%
Plasminogen Activation
25%